Journal of Investigative Medicine High Impact Case Reports (Feb 2022)

Two Cases of Miliary and Disseminated Coccidioidomycosis Following Glucocorticoid Therapy and Literature Review

  • Rowis Sous MS4,
  • Yuliya Levkiavska MD,
  • Rupam Sharma MD,
  • Roopam Jariwal MD,
  • Daniela Amodio MD,
  • Royce H. Johnson MD,
  • Arash Heidari MD,
  • Rasha Kuran MD

DOI
https://doi.org/10.1177/23247096211051928
Journal volume & issue
Vol. 10

Abstract

Read online

A 49-year-old man with no significant past medical history received dexamethasone as part of his treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Less than 3 weeks later, the patient developed acute respiratory distress syndrome. Radiological and serological testing led to a diagnosis of acute hypoxic miliary coccidioidomycosis. A 52-year-old man with a past medical history of chronic kidney disease (CKD) was treated with prednisone for focal segmental glomerulosclerosis (FSGS). Within 2 weeks, this patient developed bilateral lower extremity weakness. Radiology, serology, and lumbar puncture proved a diagnosis of reactivated coccidioidomycosis with miliary pattern and coccidioidomycosis meningoencephalitis with arachnoiditis. Whether treatment with glucocorticoids caused reactivation of coccidioidomycosis is discussed in this case series.